Mark Genovese

Mark Genovese is currently the Senior Vice President of Immunology Development at Eli Lilly. They serve on the Board of Directors for Lupus Therapeutics INC and Kyverna Therapeutics. Previously, Mark held the role of Senior Vice President of Inflammation Development at Gilead Sciences and was a James W. Raitt Endowed Professor of Medicine--Emeritus at Stanford University. Their academic career includes various positions at Stanford University, where they contributed to the fields of Medicine, Immunology, and Rheumatology. Mark's educational background comprises a Doctor of Medicine from The Johns Hopkins University and a Bachelor of Science from the University of Notre Dame.